L Lacomblez Selected Research

Alzheimer Disease (Alzheimer's Disease)

7/2002

[Perturbations of activities of daily living in Alzheimer's disease. A study of 172 patients with the using a questionnaire completed by caregivers].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Lacomblez Research Topics

Disease

6	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2014 - 09/2000
2	Parkinsonian Disorders (Parkinsonism) 01/2017 - 06/2000
2	Disease Progression 03/2008 - 04/2002
2	Nausea 01/2006 - 01/2002
2	Atrial Fibrillation 01/2001 - 11/2000
1	Nervous System Diseases (Neurological Disorders) 06/2015
1	Facioscapulohumeral Muscular Dystrophy 07/2009
1	Hyperlipidemias (Hyperlipidemia) 03/2008
1	Deglutition Disorders (Dysphagia) 01/2006
1	Flushing 01/2006
1	Fasciculation (Fasciculations) 03/2005
1	Atrophy 03/2005
1	Cough 03/2005
1	Alzheimer Disease (Alzheimer's Disease) 07/2002
1	Dementia (Dementias) 07/2002
1	Disorders of Excessive Somnolence (Hypersomnia) 04/2002
1	Apnea 04/2002
1	Sleepiness 04/2002
1	Asthenia 01/2002
1	Pallidopyramidal syndrome 07/2001
1	Cognitive Dysfunction 01/2001
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2001
1	Hemorrhage 01/2001
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2000
1	Dyskinesias (Dyskinesia) 06/2000
1	Dystonia (Limb Dystonia) 06/2000
1	Paraplegia (Spastic Paraplegia) 06/2000
1	Dopa-responsive Dystonia 06/2000

Drug/Important Bio-Agent (IBA)

6	Riluzole FDA LinkGeneric 03/2014 - 12/2000
2	Pharmaceutical PreparationsIBA 06/2015 - 01/2006
2	Levodopa (L Dopa)FDA LinkGeneric 04/2002 - 06/2000
2	fluindioneIBA 01/2001 - 11/2000
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2001 - 11/2000
2	AnticoagulantsIBA 01/2001 - 11/2000
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	olesoximeIBA 03/2014
1	Albuterol (Salbutamol)FDA LinkGeneric 07/2009
1	oxidized low density lipoproteinIBA 03/2008
1	LipidsIBA 03/2008
1	CholesterolIBA 03/2008
1	CreatinineIBA 03/2005
1	Biological ProductsIBA 03/2005
1	Neuroprotective AgentsIBA 05/2002
1	Dopamine Agents (Dopaminergic Agents)IBA 04/2002
1	Apolipoproteins E (ApoE)IBA 04/2002
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2002
1	Transaminases (Aminotransferases)IBA 01/2002
1	Flumazenil (Romazicon)FDA LinkGeneric 07/2001
1	GABA-A Receptors (GABA(A) Receptor)IBA 07/2001
1	Free RadicalsIBA 09/2000
1	Guanosine Triphosphate (GTP)IBA 06/2000

Therapy/Procedure

1	Ambulatory Care (Outpatient Care) 01/2017
1	Activities of Daily Living (ADL) 07/2002
1	Drug Therapy (Chemotherapy) 04/2002
1	Highly Active Antiretroviral Therapy (HAART) 01/2001
1	Therapeutics 11/2000